New Antibiotics Study Findings Have Been Reported from World Health Organization (WHO) (Multi-year analysis of the global preclinical antibacterial pipeline: trends and gaps).

A recent study conducted by the World Health Organization (WHO) highlights the urgent need for new antibiotics to combat antimicrobial resistance (AMR), which is a significant global health threat. The study emphasizes that AMR not only poses a risk to public health but also has severe economic consequences, particularly in low- and middle-income countries. The WHO calls for the continuous development of new antibacterial medicines to address resistant bacterial strains. The study examines trends in preclinical development and identifies gaps and potential opportunities to overcome challenges in the early stages of antibacterial research and development. [Extracted from the article]